Navigation path

Pharmaceuticals - Community Register


Community register of orphan medicinal products


Product information

4-[3-(methylsulfonyl)phenyl]-1-propylpiperidine x HCl

EU orphan designation number: EU/3/05/288   
Active ingredient: 4-[3-(methylsulfonyl)phenyl]-1-propylpiperidine x HCl
Indication: Treatment of Huntington's disease
Sponsor: Teva Pharma GmbH
Graf-Arco-Straße 3, D-89079 Ulm, Deutschland

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
22/06/2005 Orphan Designation EMEA/OD/011/05 (2005)1908 of 20/06/2005
21/06/2007 Other procedure
30/07/2009 Transfer of orphan designation EMEA/OD/011/05/T/01 (2009)6043 of 24/07/2009
30/04/2013 Transfer of orphan designation EMEA/OD/011/05/T/02 (2013)2563 of 26/04/2013